Page last updated: 2024-09-02

1-(carboxymethylthio)tetradecane and Hyperlipemia

1-(carboxymethylthio)tetradecane has been researched along with Hyperlipemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bisgaier, CL; Cramer, CT; Dasseux, JL; Denisenko, S; Duan, C; Freiman, CD; Geoffroy, OJ; Goetz, B; Hopson, KL; Huang, TB; McCosar, BH; Mueller, R; Oniciu, DC; Pape, ME; Pop, E; Yang, J; Zhang, LH1
Aasum, E; Berge, RK; Boardman, N; Hafstad, AD; Hagve, M; Khalid, AM; Larsen, TS; Severson, DL1
Aukrust, P; Berge, RK; Bohov, P; Dyrøy, E; Fredriksen, J; Frøland, SS; Halvorsen, B; Melby, K; Melbye, L; Skalhegg, BS; Skorve, J; Ueland, T1

Other Studies

3 other study(ies) available for 1-(carboxymethylthio)tetradecane and Hyperlipemia

ArticleYear
Long hydrocarbon chain keto diols and diacids that favorably alter lipid disorders in vivo.
    Journal of medicinal chemistry, 2004, Nov-18, Volume: 47, Issue:24

    Topics: Alcohols; Animals; Cells, Cultured; Cholesterol, HDL; Diabetes Mellitus; Dicarboxylic Acids; Dose-Response Relationship, Drug; Female; Hepatocytes; Hydrocarbons; Hyperlipidemias; Hypolipidemic Agents; Keto Acids; Ketones; Lipids; Male; Metabolic Diseases; Rats; Rats, Sprague-Dawley; Rats, Zucker

2004
Cardioprotective effect of the PPAR ligand tetradecylthioacetic acid in type 2 diabetic mice.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:6

    Topics: Animals; Antioxidants; Cardiotonic Agents; Diabetes Mellitus, Type 2; Disease Models, Animal; Electron Transport; Fatty Acids; Heart; Hyperlipidemias; Ligands; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardium; Oxidation-Reduction; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Sulfides

2011
Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy.
    European journal of clinical investigation, 2004, Volume: 34, Issue:10

    Topics: Adult; Animals; Anti-Inflammatory Agents; Female; HIV Infections; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Leukocytes, Mononuclear; Lipids; Male; Mice; Middle Aged; Pilot Projects; Receptors, Immunologic; Receptors, Scavenger; Reverse Transcriptase Polymerase Chain Reaction; Sulfides; Up-Regulation

2004